COVID-19 Outbreak-Global Biosimilar Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

January 2021 | 121 pages | ID: CB2C5E8D7810EN
Maia Research

Abstracts

A biosimilar is a biological product that is very similar to a reference biologic and for which there are no clinically meaningful differences in terms of safety, purity, and potency.

The Biosimilar market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Biosimilar industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Biosimilar market can be split based on product types, major applications, and important countries as follows:

Key players in the global Biosimilar market covered in Chapter 12:

Sun pharma
MYLAN
Changchun High Tech
Gelgen Biopharma
Hospira (Pfizer)
3sbio
Teva Pharmaceutical
SANDOZ (NOVARTIS)
CP Guojian Pharmacy
Biotech Pharma

In Chapter 4 and 14.1, on the basis of types, the Biosimilar market from 2015 to 2025 is primarily split into:

Predictive Testing
Carrier Testing
Prenatal And Newborn Testing
Diagnostic Testing
Pharmacogenomic Testing

In Chapter 5 and 14.2, on the basis of applications, the Biosimilar market from 2015 to 2025 covers:

Infectious Disease
Blood Screening
Genetic Testing
Oncology Testing

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Contents

1 BIOSIMILAR INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Overview of Biosimilar
1.3 Scope of The Study
  1.3.1 Key Market Segments
  1.3.2 Players Covered
  1.3.3 COVID-19's impact on the Biosimilar industry
1.4 Methodology of The Study
1.5 Research Data Source

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Biosimilar Market Size, 2015 – 2020
  2.1.2 Global Biosimilar Market Size by Type, 2015 – 2020
  2.1.3 Global Biosimilar Market Size by Application, 2015 – 2020
  2.1.4 Global Biosimilar Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
  2.2.1 Global COVID-19 Status and Economic Overview
  2.2.2 Influence of COVID-19 Outbreak on Biosimilar Industry Development

3 INDUSTRY CHAIN ANALYSIS

3.1 Upstream Raw Material Suppliers of Biosimilar Analysis
3.2 Major Players of Biosimilar
3.3 Biosimilar Manufacturing Cost Structure Analysis
  3.3.1 Production Process Analysis
  3.3.2 Manufacturing Cost Structure of Biosimilar
  3.3.3 Labor Cost of Biosimilar
3.4 Market Distributors of Biosimilar
3.5 Major Downstream Buyers of Biosimilar Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 GLOBAL BIOSIMILAR MARKET, BY TYPE

4.1 Global Biosimilar Value and Market Share by Type (2015-2020)
4.2 Global Biosimilar Production and Market Share by Type (2015-2020)
4.3 Global Biosimilar Value and Growth Rate by Type (2015-2020)
  4.3.1 Global Biosimilar Value and Growth Rate of Predictive Testing
  4.3.2 Global Biosimilar Value and Growth Rate of Carrier Testing
  4.3.3 Global Biosimilar Value and Growth Rate of Prenatal And Newborn Testing
  4.3.4 Global Biosimilar Value and Growth Rate of Diagnostic Testing
  4.3.5 Global Biosimilar Value and Growth Rate of Pharmacogenomic Testing
4.4 Global Biosimilar Price Analysis by Type (2015-2020)

5 BIOSIMILAR MARKET, BY APPLICATION

5.1 Downstream Market Overview
5.2 Global Biosimilar Consumption and Market Share by Application (2015-2020)
5.3 Global Biosimilar Consumption and Growth Rate by Application (2015-2020)
  5.3.1 Global Biosimilar Consumption and Growth Rate of Infectious Disease (2015-2020)
  5.3.2 Global Biosimilar Consumption and Growth Rate of Blood Screening (2015-2020)
  5.3.3 Global Biosimilar Consumption and Growth Rate of Genetic Testing (2015-2020)
  5.3.4 Global Biosimilar Consumption and Growth Rate of Oncology Testing (2015-2020)

6 GLOBAL BIOSIMILAR MARKET ANALYSIS BY REGIONS

6.1 Global Biosimilar Sales, Revenue and Market Share by Regions
  6.1.1 Global Biosimilar Sales by Regions (2015-2020)
  6.1.2 Global Biosimilar Revenue by Regions (2015-2020)
6.2 North America Biosimilar Sales and Growth Rate (2015-2020)
6.3 Europe Biosimilar Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Biosimilar Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Biosimilar Sales and Growth Rate (2015-2020)
6.6 South America Biosimilar Sales and Growth Rate (2015-2020)

7 NORTH AMERICA BIOSIMILAR MARKET ANALYSIS BY COUNTRIES

7.1 The Influence of COVID-19 on North America Market
7.2 North America Biosimilar Sales, Revenue and Market Share by Countries
  7.2.1 North America Biosimilar Sales by Countries (2015-2020)
  7.2.2 North America Biosimilar Revenue by Countries (2015-2020)
7.3 United States Biosimilar Sales and Growth Rate (2015-2020)
7.4 Canada Biosimilar Sales and Growth Rate (2015-2020)
7.5 Mexico Biosimilar Sales and Growth Rate (2015-2020)

8 EUROPE BIOSIMILAR MARKET ANALYSIS BY COUNTRIES

8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Biosimilar Sales, Revenue and Market Share by Countries
  8.2.1 Europe Biosimilar Sales by Countries (2015-2020)
  8.2.2 Europe Biosimilar Revenue by Countries (2015-2020)
8.3 Germany Biosimilar Sales and Growth Rate (2015-2020)
8.4 UK Biosimilar Sales and Growth Rate (2015-2020)
8.5 France Biosimilar Sales and Growth Rate (2015-2020)
8.6 Italy Biosimilar Sales and Growth Rate (2015-2020)
8.7 Spain Biosimilar Sales and Growth Rate (2015-2020)
8.8 Russia Biosimilar Sales and Growth Rate (2015-2020)

9 ASIA PACIFIC BIOSIMILAR MARKET ANALYSIS BY COUNTRIES

9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Biosimilar Sales, Revenue and Market Share by Countries
  9.2.1 Asia Pacific Biosimilar Sales by Countries (2015-2020)
  9.2.2 Asia Pacific Biosimilar Revenue by Countries (2015-2020)
9.3 China Biosimilar Sales and Growth Rate (2015-2020)
9.4 Japan Biosimilar Sales and Growth Rate (2015-2020)
9.5 South Korea Biosimilar Sales and Growth Rate (2015-2020)
9.6 India Biosimilar Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Biosimilar Sales and Growth Rate (2015-2020)
9.8 Australia Biosimilar Sales and Growth Rate (2015-2020)

10 MIDDLE EAST AND AFRICA BIOSIMILAR MARKET ANALYSIS BY COUNTRIES

10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Countries
  10.2.1 Middle East and Africa Biosimilar Sales by Countries (2015-2020)
  10.2.2 Middle East and Africa Biosimilar Revenue by Countries (2015-2020)
10.3 Saudi Arabia Biosimilar Sales and Growth Rate (2015-2020)
10.4 UAE Biosimilar Sales and Growth Rate (2015-2020)
10.5 Egypt Biosimilar Sales and Growth Rate (2015-2020)
10.6 Nigeria Biosimilar Sales and Growth Rate (2015-2020)
10.7 South Africa Biosimilar Sales and Growth Rate (2015-2020)

11 SOUTH AMERICA BIOSIMILAR MARKET ANALYSIS BY COUNTRIES

11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Biosimilar Sales, Revenue and Market Share by Countries
  11.2.1 South America Biosimilar Sales by Countries (2015-2020)
  11.2.2 South America Biosimilar Revenue by Countries (2015-2020)
11.3 Brazil Biosimilar Sales and Growth Rate (2015-2020)
11.4 Argentina Biosimilar Sales and Growth Rate (2015-2020)
11.5 Columbia Biosimilar Sales and Growth Rate (2015-2020)
11.6 Chile Biosimilar Sales and Growth Rate (2015-2020)

12 COMPETITIVE LANDSCAPE

12.1 Sun pharma
  12.1.1 Sun pharma Basic Information
  12.1.2 Biosimilar Product Introduction
  12.1.3 Sun pharma Production, Value, Price, Gross Margin 2015-2020
12.2 MYLAN
  12.2.1 MYLAN Basic Information
  12.2.2 Biosimilar Product Introduction
  12.2.3 MYLAN Production, Value, Price, Gross Margin 2015-2020
12.3 Changchun High Tech
  12.3.1 Changchun High Tech Basic Information
  12.3.2 Biosimilar Product Introduction
  12.3.3 Changchun High Tech Production, Value, Price, Gross Margin 2015-2020
12.4 Gelgen Biopharma
  12.4.1 Gelgen Biopharma Basic Information
  12.4.2 Biosimilar Product Introduction
  12.4.3 Gelgen Biopharma Production, Value, Price, Gross Margin 2015-2020
12.5 Hospira (Pfizer)
  12.5.1 Hospira (Pfizer) Basic Information
  12.5.2 Biosimilar Product Introduction
  12.5.3 Hospira (Pfizer) Production, Value, Price, Gross Margin 2015-2020
12.6 3sbio
  12.6.1 3sbio Basic Information
  12.6.2 Biosimilar Product Introduction
  12.6.3 3sbio Production, Value, Price, Gross Margin 2015-2020
12.7 Teva Pharmaceutical
  12.7.1 Teva Pharmaceutical Basic Information
  12.7.2 Biosimilar Product Introduction
  12.7.3 Teva Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
12.8 SANDOZ (NOVARTIS)
  12.8.1 SANDOZ (NOVARTIS) Basic Information
  12.8.2 Biosimilar Product Introduction
  12.8.3 SANDOZ (NOVARTIS) Production, Value, Price, Gross Margin 2015-2020
12.9 CP Guojian Pharmacy
  12.9.1 CP Guojian Pharmacy Basic Information
  12.9.2 Biosimilar Product Introduction
  12.9.3 CP Guojian Pharmacy Production, Value, Price, Gross Margin 2015-2020
12.10 Biotech Pharma
  12.10.1 Biotech Pharma Basic Information
  12.10.2 Biosimilar Product Introduction
  12.10.3 Biotech Pharma Production, Value, Price, Gross Margin 2015-2020

13 INDUSTRY OUTLOOK

13.1 Market Driver Analysis
  13.1.2 Market Restraints Analysis
  13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 GLOBAL BIOSIMILAR MARKET FORECAST

14.1 Global Biosimilar Market Value & Volume Forecast, by Type (2020-2025)
  14.1.1 Predictive Testing Market Value and Volume Forecast (2020-2025)
  14.1.2 Carrier Testing Market Value and Volume Forecast (2020-2025)
  14.1.3 Prenatal And Newborn Testing Market Value and Volume Forecast (2020-2025)
  14.1.4 Diagnostic Testing Market Value and Volume Forecast (2020-2025)
  14.1.5 Pharmacogenomic Testing Market Value and Volume Forecast (2020-2025)
14.2 Global Biosimilar Market Value & Volume Forecast, by Application (2020-2025)
  14.2.1 Infectious Disease Market Value and Volume Forecast (2020-2025)
  14.2.2 Blood Screening Market Value and Volume Forecast (2020-2025)
  14.2.3 Genetic Testing Market Value and Volume Forecast (2020-2025)
  14.2.4 Oncology Testing Market Value and Volume Forecast (2020-2025)
14.3 Biosimilar Market Analysis and Forecast by Region
  14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 NEW PROJECT FEASIBILITY ANALYSIS

15.1 Industry Barriers and New Entrants SWOT Analysis
  15.1.1 Porter’s Five Forces Analysis
  15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilar
Table Product Specification of Biosimilar
Table Biosimilar Key Market Segments
Table Key Players Biosimilar Covered
Figure Global Biosimilar Market Size, 2015 – 2025
Table Different Types of Biosimilar
Figure Global Biosimilar Value ($) Segment by Type from 2015-2020
Figure Global Biosimilar Market Share by Types in 2019
Table Different Applications of Biosimilar
Figure Global Biosimilar Value ($) Segment by Applications from 2015-2020
Figure Global Biosimilar Market Share by Applications in 2019
Figure Global Biosimilar Market Share by Regions in 2019
Figure North America Biosimilar Production Value ($) and Growth Rate (2015-2020)
Figure Europe Biosimilar Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Biosimilar Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilar Production Value ($) and Growth Rate (2015-2020)
Figure South America Biosimilar Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Biosimilar
Table Upstream Raw Material Suppliers of Biosimilar with Contact Information
Table Major Players Headquarters, and Service Area of Biosimilar
Figure Major Players Production Value Market Share of Biosimilar in 2019
Table Major Players Biosimilar Product Types in 2019
Figure Production Process of Biosimilar
Figure Manufacturing Cost Structure of Biosimilar
Figure Channel Status of Biosimilar
Table Major Distributors of Biosimilar with Contact Information
Table Major Downstream Buyers of Biosimilar with Contact Information
Table Global Biosimilar Value ($) by Type (2015-2020)
Table Global Biosimilar Value Share by Type (2015-2020)
Figure Global Biosimilar Value Share by Type (2015-2020)
Table Global Biosimilar Production by Type (2015-2020)
Table Global Biosimilar Production Share by Type (2015-2020)
Figure Global Biosimilar Production Share by Type (2015-2020)
Figure Global Biosimilar Value ($) and Growth Rate of Predictive Testing (2015-2020)
Figure Global Biosimilar Value ($) and Growth Rate of Carrier Testing (2015-2020)
Figure Global Biosimilar Value ($) and Growth Rate of Prenatal And Newborn Testing (2015-2020)
Figure Global Biosimilar Value ($) and Growth Rate of Diagnostic Testing (2015-2020)
Figure Global Biosimilar Value ($) and Growth Rate of Pharmacogenomic Testing (2015-2020)
Figure Global Biosimilar Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Biosimilar Consumption by Application (2015-2020)
Table Global Biosimilar Consumption Market Share by Application (2015-2020)
Figure Global Biosimilar Consumption Market Share by Application (2015-2020)
Figure Global Biosimilar Consumption and Growth Rate of Infectious Disease (2015-2020)
Figure Global Biosimilar Consumption and Growth Rate of Blood Screening (2015-2020)
Figure Global Biosimilar Consumption and Growth Rate of Genetic Testing (2015-2020)
Figure Global Biosimilar Consumption and Growth Rate of Oncology Testing (2015-2020)
Figure Global Biosimilar Sales and Growth Rate (2015-2020)
Figure Global Biosimilar Revenue (M USD) and Growth (2015-2020)
Table Global Biosimilar Sales by Regions (2015-2020)
Table Global Biosimilar Sales Market Share by Regions (2015-2020)
Table Global Biosimilar Revenue (M USD) by Regions (2015-2020)
Table Global Biosimilar Revenue Market Share by Regions (2015-2020)
Table Global Biosimilar Revenue Market Share by Regions in 2015
Table Global Biosimilar Revenue Market Share by Regions in 2019
Figure North America Biosimilar Sales and Growth Rate (2015-2020)
Figure Europe Biosimilar Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilar Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilar Sales and Growth Rate (2015-2020)
Figure South America Biosimilar Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Biosimilar Revenue (M USD) and Growth (2015-2020)
Table North America Biosimilar Sales by Countries (2015-2020)
Table North America Biosimilar Sales Market Share by Countries (2015-2020)
Table North America Biosimilar Revenue (M USD) by Countries (2015-2020)
Table North America Biosimilar Revenue Market Share by Countries (2015-2020)
Figure United States Biosimilar Sales and Growth Rate (2015-2020)
Figure Canada Biosimilar Sales and Growth Rate (2015-2020)
Figure Mexico Biosimilar Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Biosimilar Revenue (M USD) and Growth (2015-2020)
Table Europe Biosimilar Sales by Countries (2015-2020)
Table Europe Biosimilar Sales Market Share by Countries (2015-2020)
Table Europe Biosimilar Revenue (M USD) by Countries (2015-2020)
Table Europe Biosimilar Revenue Market Share by Countries (2015-2020)
Figure Germany Biosimilar Sales and Growth Rate (2015-2020)
Figure UK Biosimilar Sales and Growth Rate (2015-2020)
Figure France Biosimilar Sales and Growth (2015-2020)
Figure Italy Biosimilar Sales and Growth (2015-2020)
Figure Spain Biosimilar Sales and Growth (2015-2020)
Figure Russia Biosimilar Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Biosimilar Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Biosimilar Sales by Countries (2015-2020)
Table Asia Pacific Biosimilar Sales Market Share by Countries (2015-2020)
Table Asia Pacific Biosimilar Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Biosimilar Revenue Market Share by Countries (2015-2020)
Figure China Biosimilar Sales and Growth Rate (2015-2020)
Figure Japan Biosimilar Sales and Growth Rate (2015-2020)
Figure South Korea Biosimilar Sales and Growth (2015-2020)
Figure India Biosimilar Sales and Growth (2015-2020)
Figure Southeast Asia Biosimilar Sales and Growth (2015-2020)
Figure Australia Biosimilar Sales and Growth (2015-2020)
Figure Middle East Biosimilar Revenue (M USD) and Growth (2015-2020)
Table Middle East Biosimilar Sales by Countries (2015-2020)
Table Middle East and Africa Biosimilar Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Biosimilar Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Biosimilar Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Biosimilar Sales and Growth Rate (2015-2020)
Figure UAE Biosimilar Sales and Growth Rate (2015-2020)
Figure Egypt Biosimilar Sales and Growth (2015-2020)
Figure Nigeria Biosimilar Sales and Growth (2015-2020)
Figure South Africa Biosimilar Sales and Growth (2015-2020)
Figure South America Biosimilar Revenue (M USD) and Growth (2015-2020)
Table South America Biosimilar Sales by Countries (2015-2020)
Table South America Biosimilar Sales Market Share by Countries (2015-2020)
Table South America Biosimilar Revenue (M USD) by Countries (2015-2020)
Table South America Biosimilar Revenue Market Share by Countries (2015-2020)
Figure Brazil Biosimilar Sales and Growth Rate (2015-2020)
Figure Argentina Biosimilar Sales and Growth Rate (2015-2020)
Figure Columbia Biosimilar Sales and Growth (2015-2020)
Figure Chile Biosimilar Sales and Growth (2015-2020)
Figure Top 3 Market Share of Biosimilar Companies in 2019
Figure Top 6 Market Share of Biosimilar Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Sun pharma Profile
Table Sun pharma Product Introduction
Figure Sun pharma Production and Growth Rate
Figure Sun pharma Value ($) Market Share 2015-2020
Table MYLAN Profile
Table MYLAN Product Introduction
Figure MYLAN Production and Growth Rate
Figure MYLAN Value ($) Market Share 2015-2020
Table Changchun High Tech Profile
Table Changchun High Tech Product Introduction
Figure Changchun High Tech Production and Growth Rate
Figure Changchun High Tech Value ($) Market Share 2015-2020
Table Gelgen Biopharma Profile
Table Gelgen Biopharma Product Introduction
Figure Gelgen Biopharma Production and Growth Rate
Figure Gelgen Biopharma Value ($) Market Share 2015-2020
Table Hospira (Pfizer) Profile
Table Hospira (Pfizer) Product Introduction
Figure Hospira (Pfizer) Production and Growth Rate
Figure Hospira (Pfizer) Value ($) Market Share 2015-2020
Table 3sbio Profile
Table 3sbio Product Introduction
Figure 3sbio Production and Growth Rate
Figure 3sbio Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Profile
Table Teva Pharmaceutical Product Introduction
Figure Teva Pharmaceutical Production and Growth Rate
Figure Teva Pharmaceutical Value ($) Market Share 2015-2020
Table SANDOZ (NOVARTIS) Profile
Table SANDOZ (NOVARTIS) Product Introduction
Figure SANDOZ (NOVARTIS) Production and Growth Rate
Figure SANDOZ (NOVARTIS) Value ($) Market Share 2015-2020
Table CP Guojian Pharmacy Profile
Table CP Guojian Pharmacy Product Introduction
Figure CP Guojian Pharmacy Production and Growth Rate
Figure CP Guojian Pharmacy Value ($) Market Share 2015-2020
Table Biotech Pharma Profile
Table Biotech Pharma Product Introduction
Figure Biotech Pharma Production and Growth Rate
Figure Biotech Pharma Value ($) Market Share 2015-2020
Table Market Driving Factors of Biosimilar
Table Merger, Acquisition and New Investment
Table Global Biosimilar Market Value ($) Forecast, by Type
Table Global Biosimilar Market Volume Forecast, by Type
Figure Global Biosimilar Market Value ($) and Growth Rate Forecast of Predictive Testing (2020-2025)
Figure Global Biosimilar Market Volume ($) and Growth Rate Forecast of Predictive Testing (2020-2025)
Figure Global Biosimilar Market Value ($) and Growth Rate Forecast of Carrier Testing (2020-2025)
Figure Global Biosimilar Market Volume ($) and Growth Rate Forecast of Carrier Testing (2020-2025)
Figure Global Biosimilar Market Value ($) and Growth Rate Forecast of Prenatal And Newborn Testing (2020-2025)
Figure Global Biosimilar Market Volume ($) and Growth Rate Forecast of Prenatal And Newborn Testing (2020-2025)
Figure Global Biosimilar Market Value ($) and Growth Rate Forecast of Diagnostic Testing (2020-2025)
Figure Global Biosimilar Market Volume ($) and Growth Rate Forecast of Diagnostic Testing (2020-2025)
Figure Global Biosimilar Market Value ($) and Growth Rate Forecast of Pharmacogenomic Testing (2020-2025)
Figure Global Biosimilar Market Volume ($) and Growth Rate Forecast of Pharmacogenomic Testing (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Infectious Disease (2020-2025)
Figure Market Volume and Growth Rate Forecast of Infectious Disease (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Blood Screening (2020-2025)
Figure Market Volume and Growth Rate Forecast of Blood Screening (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Genetic Testing (2020-2025)
Figure Market Volume and Growth Rate Forecast of Genetic Testing (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Oncology Testing (2020-2025)
Figure Market Volume and Growth Rate Forecast of Oncology Testing (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery